| Original language | English (US) |
|---|---|
| Pages (from-to) | 2013-2018 |
| Number of pages | 6 |
| Journal | Journal of Nuclear Cardiology |
| Volume | 29 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2022 |
Keywords
- COVID-19
- Cardiology
- Humans
- Laboratories
- Pandemics
- SARS-CoV-2
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Radiology Nuclear Medicine and imaging
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Nuclear Cardiology, Vol. 29, No. 4, 08.2022, p. 2013-2018.
Research output: Contribution to journal › Review article › peer-review
}
TY - JOUR
T1 - Update on guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic
T2 - Emphasis on transition to chronic endemic state. An information statement from ASNC, IAEA, and SNMMI
AU - Thompson, Randall C.
AU - Phillips, Lawrence M.
AU - Dilsizian, Vasken
AU - Gutierrez, Diana Paez
AU - Einstein, Andrew J.
AU - Crews, Suzanne F.
AU - Skali, Hicham
AU - Jih, Felix Keng Yung
AU - Dondi, Maurizio
AU - Gimelli, Alessia
AU - Bateman, Timothy M.
AU - Al-Mallah, Mouaz H.
AU - Ghesani, Munir
AU - Dorbala, Sharmila
AU - Calnon, Dennis A.
N1 - Funding Information: Dr. Al-Mallah has served as a consultant to Pfizer, Philips, and Jubilant; he has received grant support from Siemens. Dr. Bateman holds intellectual property rights in and receives royalties from Cardiovascular Imaging Technologies; he has served as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare; and he has received grant support from Bracco, JDI Solutions, and GE Healthcare. Dr. Dilsizian has received grant support from GE Healthcare. Dr. Dorbala has received grant support from Pfizer, GE Healthcare, and Attalus; she serves on the advisory board for Pfizer, GE healthcare, Janssen, and Eidos; she serves on the speakers’ bureau for Ionetix. Dr. Einstein has received speaker fees from Ionetix; has received consulting fees from W. L. Gore & Associates; has received authorship fees from Wolters Kluwer Healthcare – UpToDate; and has received grants or grants pending to his institution from Attralus, Canon Medical Systems, Eidos Therapeutics, GE Healthcare, Pfizer, Roche Medical Systems, and W. L. Gore & Associates, and XyloCor Therapeutics. Dr. Ghesani serves on the advisory board for GE Healthcare; he serves on the speakers’ bureau for Blue Earth and Novartis. Dr. Gimelli serves on the advisory board for Pfizer and GE Healthcare. Dr. Phillips serves as a consultant to NovoNordisk. Dr. Skali serves as a consultant to Astellas and has received research support form ABT Associates. The following contributors have nothing relevant to disclose: Dennis A. Calnon, MD, MASNC; Suzanne F. Crews, MPA, RT, NMTCB; Maurizio Dondi, MD; Felix Keng Yung Jih, MBBS, MASNC; Diana Paez Gutierrez, MD; Randall C. Thompson, MD, MASNC.
PY - 2022/8
Y1 - 2022/8
KW - COVID-19
KW - Cardiology
KW - Humans
KW - Laboratories
KW - Pandemics
KW - SARS-CoV-2
UR - http://www.scopus.com/inward/record.url?scp=85129827230&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85129827230&partnerID=8YFLogxK
U2 - 10.1007/s12350-022-02984-9
DO - 10.1007/s12350-022-02984-9
M3 - Review article
C2 - 35499661
AN - SCOPUS:85129827230
SN - 1071-3581
VL - 29
SP - 2013
EP - 2018
JO - Journal of Nuclear Cardiology
JF - Journal of Nuclear Cardiology
IS - 4
ER -